| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P50 | author | Donald G Catanzaro | Q59677230 |
| P2093 | author name string | Timothy C Rodwell | |
| Antonino Catanzaro | |||
| Marva Seifert | |||
| P2860 | cites work | Scaling up tuberculosis culture services: a precautionary note | Q84126870 |
| [Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains] | Q84953436 | ||
| Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update | Q28143206 | ||
| Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis | Q28248794 | ||
| Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations | Q28397752 | ||
| Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis | Q28469011 | ||
| Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review | Q28481845 | ||
| The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis | Q29615201 | ||
| inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis | Q29617412 | ||
| Molecular determinants of drug resistance in tuberculosis. | Q30326258 | ||
| Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism | Q33722028 | ||
| Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis | Q33826352 | ||
| Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review | Q33869390 | ||
| Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009 | Q33988089 | ||
| Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact | Q34224000 | ||
| Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis | Q34933405 | ||
| Antitubercular isoniazid and drug resistance of Mycobacterium tuberculosis--a review | Q35069679 | ||
| Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa | Q35137375 | ||
| The diagnosis and therapy of tuberculosis during the past 100 years | Q36040118 | ||
| Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives | Q37092384 | ||
| Isoniazid resistance and the future of drug-resistant tuberculosis | Q37120865 | ||
| Molecular diagnostic tools in mycobacteriology | Q37206602 | ||
| Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens | Q37546274 | ||
| Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis | Q37574588 | ||
| New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis | Q37854382 | ||
| Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance | Q37855147 | ||
| Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing | Q37868321 | ||
| Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis. | Q37891160 | ||
| Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities | Q39783805 | ||
| Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons | Q39990886 | ||
| Mechanisms of drug resistance in Mycobacterium tuberculosis | Q43253948 | ||
| Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. | Q43674043 | ||
| Variations in the occurrence of the S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Kuwait | Q44064394 | ||
| Resistant tuberculosis: a molecular review | Q44168515 | ||
| Detecting drug-resistant tuberculosis: the importance of rapid testing. | Q51532520 | ||
| Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. | Q53590893 | ||
| Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report. | Q54741647 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mutation | Q42918 |
| Mycobacterium tuberculosis | Q130971 | ||
| multidrug-resistant tuberculosis | Q866602 | ||
| bacterial multiple drug resistance | Q2878482 | ||
| isoniazid | Q423169 | ||
| antituberculous drug | Q584144 | ||
| bacterial protein | Q64923821 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e0119628 | |
| P577 | publication date | 2015-03-23 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review | |
| P478 | volume | 10 |
| Q33812455 | A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis |
| Q89597699 | A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer |
| Q53223810 | A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study. |
| Q90160906 | A pilot study: VereMTB detection kit for rapid detection of multidrug-resistant mycobcterium tuberculosis in clinical sputum samples |
| Q39094119 | Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis. |
| Q37034701 | Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor |
| Q90216898 | Association Between the Phenotype and Genotype of Isoniazid Resistance Among Mycobacterium tuberculosis Isolates in Thailand |
| Q56909998 | Bacterial Factors That Predict Relapse after Tuberculosis Therapy |
| Q92424667 | Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China |
| Q91803269 | Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis |
| Q89802931 | Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations |
| Q36322028 | Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study |
| Q57299818 | Correlation between GenoType MTBDR Assay and Phenotypic Susceptibility Test for Prothionamide in Patients with Genotypic Isoniazid Resistance |
| Q90256839 | DNA markers for tuberculosis diagnosis |
| Q37643781 | Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis |
| Q92593517 | Development and evaluation of novel bio-safe filter paper-based kits for sputum microscopy and transport to directly detect Mycobacterium tuberculosis and associated drug resistance |
| Q65002838 | Diagnostic Delays and Treatment Implications for Patients with Isoniazid-Resistant Tuberculosis: A Case Report and Review of the Literature. |
| Q33750586 | Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study. |
| Q36318992 | Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis |
| Q93229346 | Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA |
| Q33595707 | Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing |
| Q90131004 | Early discontinuation of ethambutol in pulmonary tuberculosis treatment based on results of the GenoType MTBDRplus assay: A prospective, multicenter, non-inferiority randomized trial in South Korea |
| Q53766519 | Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations. |
| Q89986745 | Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens |
| Q39576968 | Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis |
| Q47632774 | Evolution of Phenotypic and Molecular Drug Susceptibility Testing |
| Q92351388 | Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance |
| Q37023127 | Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape |
| Q57487058 | Genetic characterization of complex isolates circulating in Abuja, Nigeria |
| Q88740868 | Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil |
| Q92715362 | Genome-wide SNP and InDel mutations in Mycobacterium tuberculosis associated with rifampicin and isoniazid resistance |
| Q33864972 | Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand |
| Q100946039 | Higher genome mutation rates of Beijing lineage of Mycobacterium tuberculosis during human infection |
| Q87115344 | Identification of novel loci associated with mycobacterial isoniazid resistance |
| Q33607162 | Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis |
| Q52679975 | Isoniazid Monoresistance: A Precursor to Multidrug-Resistant Tuberculosis? |
| Q49830844 | Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations |
| Q99613491 | Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19 |
| Q89458971 | Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion |
| Q50098800 | Mechanisms of resistance against NITD-916, a direct inhibitor of Mycobacterium tuberculosis InhA. |
| Q64231749 | Molecular Evidence of Drug-Resistant Tuberculosis in the Balimo Region of Papua New Guinea |
| Q55091455 | Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains. |
| Q92306130 | Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden tuberculosis state in Brazil |
| Q58694655 | Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis |
| Q53824364 | Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. |
| Q30243915 | New antimycobacterial agents in the pre-clinical phase or beyond: recent advances in patent literature (2001-2016). |
| Q57069790 | Phenotypic and genotypic drug sensitivity of complex isolated from South Omo Zone, Southern Ethiopia |
| Q90132989 | Predictive Power of In Silico Approach to Evaluate Chemicals against M. tuberculosis: A Systematic Review |
| Q55260133 | Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda. |
| Q38950600 | Rapid Detection of Mycobacterium tuberculosis Strains Resistant to Isoniazid and/or Rifampicin: Standardization of Multiplex Polymerase Chain Reaction Analysis |
| Q28547835 | Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay |
| Q93157923 | Rapid detection of Mycobacterium tuberculosis DNA and genetic markers for Isoniazid resistance in Ziehl-Neelsen stained slides |
| Q64096714 | Rapid screening mutations of first-line-drug-resistant genes in strains by allele-specific real-time quantitative PCR |
| Q39014173 | Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis |
| Q28069943 | Resistance Mechanisms and the Future of Bacterial Enoyl-Acyl Carrier Protein Reductase (FabI) Antibiotics |
| Q92290258 | Retrospective Analysis of Archived Pyrazinamide Resistant Mycobacterium tuberculosis Complex Isolates from Uganda-Evidence of Interspecies Transmission |
| Q43062383 | Synthesis, docking study and biological evaluation of some new thiourea derivatives bearing benzenesulfonamide moiety. |
| Q91856633 | The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis |
| Q59128950 | The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China |
| Q92626175 | Tuberculosis in Liberia: high multidrug-resistance burden, transmission and diversity modelled by multiple importation events |
| Q33724198 | Use of DNA microarray chips for the rapid detection of Mycobacterium tuberculosis resistance to rifampicin and isoniazid |
| Q92575611 | Utility of Targeted, Amplicon-Based Deep Sequencing To Detect Resistance to First-Line Tuberculosis Drugs in Botswana |
| Q64136743 | Validation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular Tests |
| Q89658792 | Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran |
| Q50098804 | Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications |
| Q90950691 | Whole genome sequencing, analyses of drug resistance-conferring mutations, and correlation with transmission of Mycobacterium tuberculosis carrying katG-S315T in Hanoi, Vietnam |
| Q92541171 | Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico |
Search more.